Yamada Y, Ando K, Ikemoto Y, Tada H, Shirakawa E, Inagaki E, Shibata S, Nakamura I, Hayashi Y, Ikegami K, Uchida I
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan.
Chem Pharm Bull (Tokyo). 1997 Oct;45(10):1631-41. doi: 10.1248/cpb.45.1631.
A series of renin inhibitors containing the (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol (2-amino-3,5-anti-diol) fragment as a novel transition-state mimic was synthesized, and their biological activities were evaluated. All of the synthesized compounds containing the 2-amino-3,5-anti-diol fragment at the P1-P1' position showed high in vitro renin-inhibitory activity with IC50 values in the 10(-8)-10(-10) M range, and most of them caused a reduction of blood pressure when administered orally to salt-depleted, conscious marmosets. The inhibitor (29) with the 4-hydroxypiperidine residue at the P4 position showed the highest activity in terms of both potency and duration of the blood pressure-lowering effect.